Whereas, a 6-month insulin mixture therapy significantly decreases the plasma CTRP3 in obese patients with T2DM, compared with the levels prior to insulin treatment (Komosinska-Vassev et al., 2019). This evidence concerns the gene INS and type 2 diabetes mellitus.